Already involved in the cardiovascular field, Seven Dreamers Laboratories has been involved since 2007 in sleep disorders, which are one of the causes of cardiovascular diseases. The treatments at that time were invasive and binding.

The challenge of Seven Dreamers was to develop a device that was simple to use, lightweight and efficient.
  • Treatment
  • Evolution
  • research
  • Quality

A significant progress in the treatment of snoring

Our team of engineers and physicians focused on the treatment of snoring and Obstructive Sleep Apnea Syndrome (OSA), which have serious consequences for everyday life and health and are the cause of many road accidents.

Treatment using CPAP already existed, but its treatment continuation rate was low due to a number of limitations.

So far only continuous positive pressure machine treatment has been proven effective, but only few people accept the constraints (wearing a mask, dependence on a power supply, and noise etc.).

With the desire to improve people lives, Seven Dreamers sought to develop a device to eliminate these constraints. The concept of Nastent™ was born.

Evolution of the concept

Seven Dreamers explored several possibilities, in collaboration with universities, doctors and health professionals.

After several months of research and for the first time, the nasal treatment appeared as obvious: this is the basic idea of ​​Nastent™. Over time, many prototypes emerged.

The first took the form of a tubular grid that dilated the nostril and was named "edamame" (green soybean), because of its particular shape. The prototypes were made from various materials (metal, plastic, rubber, etc.), and tested by renowned otolaryngologists. The first prototype in the shape of a metal mesh, which although effective, proved to be uncomfortable and could cause nosebleeds.

Finally, after many tests, the team of researchers opted for the use of a rubber gum, elastic and soft. There was therefore the problem of fixation and its maintenance. The development of the attachment system has taken a long time and is now the subject of many innovations and several patents because it had to firmly hold the Nastent™ in the nose during sleep without causing pain or discomfort.

7 years of development

Another unexpected problem was the sterilization of the Nastent™, as it was found that some sterilization methods left an unpleasant odor on the device. Thus, gamma sterilization, although widespread in the medical field, had to be abandoned for a better solution. Finally, it was sterilization by high pressure with water vapor that solved this difficulty most effectively.

The prototyping and clinical design phases ultimately required 7 years of development and effort to develop the first intranasal medical device for snoring and sleep apnea: Nastent™ classic. In view of the effectiveness of Nastent™ and patient satisfaction, developments continue to further expand the therapeutic scope of Nastent™ by contributing to the well-being of users.

Pharmaceutical affairs and development

With Nastent™ being a major innovation, it was imperative to clearly demonstrate its effectiveness and the absence of adverse effects. Each prototype can not be tried on a large scale, so our doctors, experts, and we ourselves tested several of them. The most advanced prototypes were then the subject of advanced medical studies that gave birth to Nastent™ classic. Other Nastent™ devices are being developed to meet even more extensive therapeutic fields, which we look forward to sharing with you in due course.

Quality department

In compliance with the laws and regulations in force, Nastent™ has been the subject of numerous checks to ensure safety and efficiency. We control the entire production line and the components that go into it. These daily checks also extend to all raw material suppliers. Nastent™ has undergone rigorous controls which have allowed it to receive the necessary marking for placing on the market in many countries in Europe, in Asia. At each introduction to a new market, we fund clinical studies to demonstrate safety and effectiveness in each country.